PitchSend

Investor Presentaiton

Q3 growth of 8% was broad-based with contribution from all business areas and regions Q3 2022/23 revenue by business area Q3 2022/23 revenue by geography 5 Business area Ostomy Care Continence Care Reported revenue DKKm Organic growth Share of organic growth Geographic area 2,246 8% 38% European markets 9% 39% 1,993 Reported revenue DKKm Organic growth Share of organic growth 3,526 5% 33% Voice & 9% 8% Respiratory Care* 491 Other developed markets 1,570 8% 24% Wound & Skin 700 4% 5% Care Emerging markets 1,012 19% 43% Interventional 678 7% 9% Urology Coloplast Group * Part of organic growth since February 1, 2023 6,108 8% 100% Coloplast Group 6,108 8% 100% Coloplast

View entire presentation